SBH - Sally Beauty Holdings, Inc.
NYSE
->
Consumer Cyclical
->
Specialty Retail
Denton,
United States
Type: Equity
SBH price evolution
SBH
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $97.38 | $97.17 | $121 | |
| Short term investments | ||||
| Net receivables | $92.19 | $91.41 | $87.56 | $78.49 |
| Inventory | $1036.62 | $1022.38 | $1039.75 | $1007.63 |
| Total current assets | $1305.31 | $1262.56 | $1280.32 | $1262.86 |
| Long term investments | ||||
| Property, plant & equipment | $852.45 | $828.43 | $835.95 | $836.54 |
| Goodwill & intangible assets | $587.23 | $588.58 | $591.87 | |
| Total noncurrent assets | $1458.63 | $1466.22 | $1468.52 | |
| Total investments | ||||
| Total assets | $2792.9 | $2721.2 | $2746.54 | $2731.39 |
| Current liabilities | ||||
| Accounts payable | $269.42 | $234.55 | $289.61 | $267.48 |
| Deferred revenue | ||||
| Short long term debt | $185.69 | $203.79 | $151.24 | |
| Total current liabilities | $592.67 | $594.92 | $643.77 | $573.07 |
| Long term debt | $978.25 | $1436.03 | $1436.39 | $1504.23 |
| Total noncurrent liabilities | $1548.6 | $1551.92 | $1616.98 | |
| Total debt | $1621.72 | $1640.18 | $1655.46 | |
| Total liabilities | $2164.36 | $2143.53 | $2195.69 | $2190.05 |
| Shareholders' equity | ||||
| Retained earnings | $740.68 | $698.5 | $666.65 | $652.25 |
| Other shareholder equity | -$113.17 | -$121.85 | -$116.83 | -$111.96 |
| Total shareholder equity | $577.67 | $550.85 | $541.34 | |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $123 | $70.56 | $400.96 | |
| Short term investments | ||||
| Net receivables | $92.19 | $75.88 | $72.28 | $66.58 |
| Inventory | $1036.62 | $975.22 | $936.37 | $871.35 |
| Total current assets | $1305.31 | $1228 | $1132.4 | $1383.58 |
| Long term investments | ||||
| Property, plant & equipment | $852.45 | $868.44 | $830.05 | $845.05 |
| Goodwill & intangible assets | $588.25 | $576.38 | $596.74 | |
| Total noncurrent assets | $1497.25 | $1444.47 | $1463.56 | |
| Total investments | ||||
| Total assets | $2792.9 | $2725.25 | $2576.87 | $2847.13 |
| Current liabilities | ||||
| Accounts payable | $269.42 | $258.88 | $275.72 | $291.63 |
| Deferred revenue | ||||
| Short long term debt | $154.65 | $226.39 | $156.43 | |
| Total current liabilities | $592.67 | $579.26 | $667.91 | $664.88 |
| Long term debt | $978.25 | $1520.88 | $1083.04 | $1786.68 |
| Total noncurrent liabilities | $1637.24 | $1615.32 | $1901.51 | |
| Total debt | $1675.53 | $1734.2 | $1943.11 | |
| Total liabilities | $2164.36 | $2216.5 | $2283.23 | $2566.39 |
| Shareholders' equity | ||||
| Retained earnings | $740.68 | $624.77 | $440.17 | $356.97 |
| Other shareholder equity | -$113.17 | -$122.76 | $293.64 | -$94.64 |
| Total shareholder equity | $508.75 | $293.64 | $280.74 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $935.03 | $942.34 | $908.36 | $931.3 |
| Cost of revenue | $461.46 | $445.29 | $464.13 | |
| Gross Profit | $479.2 | $480.88 | $463.07 | $467.18 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $408.73 | $403.44 | $398.14 | |
| Total operating expenses | $397.37 | $409.11 | $403.5 | $398.05 |
| Operating income | $71.77 | $59.57 | $69.12 | |
| Income from continuing operations | ||||
| EBIT | $71.77 | $59.57 | $69.12 | |
| Income tax expense | $16.35 | $13.34 | $9.81 | $13.42 |
| Interest expense | -$19.86 | $20.71 | $20.52 | $17.31 |
| Net income | ||||
| Net income | $48.06 | $37.72 | $29.24 | $38.39 |
| Income (for common shares) | $37.72 | $29.24 | $38.39 | |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 30 Oct 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3717.03 | $3728.13 | $3815.57 | |
| Cost of revenue | $1829.95 | |||
| Gross Profit | $1890.33 | $1898.18 | $1919.16 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1555.95 | |||
| Total operating expenses | $1607.67 | $1573.15 | $1547.72 | |
| Operating income | $325.03 | |||
| Income from continuing operations | ||||
| EBIT | $325.03 | |||
| Income tax expense | $52.91 | $67.45 | $58.41 | |
| Interest expense | -$74.71 | $72.98 | -$75.56 | |
| Net income | ||||
| Net income | $153.41 | $184.6 | $183.55 | |
| Income (for common shares) | $184.6 | |||
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $37.72 | $29.24 | $38.39 | |
| Operating activities | ||||
| Depreciation | $28.52 | $26.95 | $28.06 | |
| Business acquisitions & disposals | -$0.22 | |||
| Stock-based compensation | $4.18 | $3.96 | $5.12 | |
| Total cash flows from operations | $47.9 | $36.94 | $51.02 | |
| Investing activities | ||||
| Capital expenditures | -$19.15 | -$14.11 | -$30.55 | |
| Investments | ||||
| Total cash flows from investing | -$108.91 | -$19.15 | -$14.11 | -$30.77 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$10.06 | -$18.8 | -$19.98 | |
| Net borrowings | -$1364.3 | -$27.33 | -$1.05 | |
| Total cash flows from financing | -$153.73 | -$28.9 | -$46.16 | -$22.78 |
| Effect of exchange rate | $1.08 | $0.36 | -$0.5 | $0.52 |
| Change in cash and equivalents | -$15.04 | $0.2 | -$23.82 | -$2 |
| (in millions $) | 30 Oct 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | $184.6 | $183.55 | $239.86 | |
| Operating activities | ||||
| Depreciation | $102.41 | $99.93 | $102.2 | |
| Business acquisitions & disposals | -$9.03 | -$3.17 | -$2.35 | |
| Stock-based compensation | $15.86 | $9.94 | $11.66 | |
| Total cash flows from operations | $249.31 | $156.5 | $381.86 | |
| Investing activities | ||||
| Capital expenditures | -$90.74 | -$99.25 | -$73.67 | |
| Investments | ||||
| Total cash flows from investing | -$108.91 | -$99.78 | -$102.42 | -$76.02 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$14.43 | -$123.4 | $3.57 | |
| Net borrowings | -$86.39 | -$250.28 | -$423.54 | |
| Total cash flows from financing | -$153.73 | -$100.82 | -$373.68 | -$419.97 |
| Effect of exchange rate | $1.08 | $3.73 | -$10.8 | $0.94 |
| Change in cash and equivalents | -$15.04 | $52.44 | -$330.4 | -$113.19 |
News
Fundamentals
| Market cap | $874.93M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 101.85M |
| Revenue | $3.72B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $153.41M |
| Revenue Q/Q | 1.48% |
| Revenue Y/Y | -0.30% |
| P/E ratio | 5.70 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.24 |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | $1.51 |
|---|---|
| ROA | 5.58% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.20 |
| Quick ratio | 0.45 |